Meridian Clinical Research (Omaha-Nebraska) - Platinum - PPDS

Omaha, Nebraska 68134

0 studies enrolling now · 3 studies all time

What they study most

Respiratory Syncytial Virus, SARS-CoV-2

Studies at this site

• A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age — Completed
• A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19 — Completed
• Moderna Vaccine mRNA-1345 Observational Respiratory Syncytial Virus (RSV) Study — Completed